Inside the discoveries, personalities, and deals driving drug development. Sign up for The Readout newsletter to get the latest on biotech delivered to your inbox. And subscribe to STAT+ to access daily, market-moving coverage of the biotech sector — from startup funding to clinical trial readouts
The study results are preliminary but establish Caribou’s presence among a group of drugmakers leveraging genome-editing technologies.
Read The Story
advertisement
